How to keep a long, tubular implantable medical device straight
By applying magnetic field traction force on long tubular implantable medical equipment, the control equipment remains straight within the range of θ≦5°, solving the bending and swaying problems caused by gravity during the production process, and improving processing quality and safety.
Patent Information
- Application Number
- JP2024537889
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-31
- Filing Date
- 2022-12-26
- Publication Date
- 2024-12-05
- Estimated Expiration
- 2042-12-26
AI Technical Summary
Long tubular implantable medical equipment is prone to bend or swaying due to gravity during the production process, resulting in unstable processing and affecting product quality and safety.
By applying magnetic field traction force, the linearity of the long tubular implantable medical device is maintained, and the magnetic field acts on the magnetic permeable material or additional magnetic material of the device is controlled to maintain a linear state within the angular range of θ≦5°.
It improves the equipment acceptance rate and detection accuracy during processing, ensures surface coating uniformity and cutting accuracy, and reduces product failure rate.
Smart Images

Figure 2024545309000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to the field of medical devices, and more particularly to a method for keeping a long, tubular, implantable medical device straight. [Background technology]
[0002] With the development of medical technology, implantable medical devices have gradually come into everyone's field of vision, mainly playing the role of supporting the affected area of the patient. For example, the stent placement technique currently commonly used for vascular lesions involves inserting a stent into the lesion site of the blood vessel to expand the stenotic blood vessel again and restore normal blood supply, thereby achieving the purpose of revascularization. Currently, it is the most effective method for treating diseases caused by vascular stenosis and insufficient blood supply (coronary heart disease, lower limb arteriosclerosis obliterans, etc.). Because implantable medical devices are implanted into the human body, if some factors in the production process cause problems such as low qualification rate and unstable quality of the device, it is easy to cause many safety problems, which will cause very noticeable side effects in the patient's body and cause pain to the patient. Therefore, at present, each country has set high standards for the quality, safety, etc. of implantable medical devices and strengthened the corresponding regulations. Manufacturers must ensure that the products meet the corresponding standards when producing the products, and avoid the corresponding safety risks as much as possible after they are implanted into the body.
[0003] In the production process, medical instruments often involve processes such as spraying, cutting, and inspection. In the above processes, the currently commonly used method is to clamp one end of the medical instrument with a jig, and the other end is suspended in the air, and then perform the corresponding operations such as spraying, cutting, and inspection. When the length of the medical instrument is relatively short, the suspended end will not bend or sag due to gravity, so there are almost no problems such as instability of the production process of the instrument due to gravity and low pass rate of the product during processing. When the length of the tubular medical instrument reaches a certain value, especially for the long tubular medical instrument with openwork design, the coverage rate of the surface material is low, and the whole instrument is light and thin, so the stent of the suspended part is easy to bend downward due to gravity. Especially in the processes such as spraying, cutting, and inspection, the instrument needs to rotate at a certain speed and within a certain range, which causes the central axis of the front and rear ends of the instrument to not overlap, resulting in significant "vibration", and the extremely fast swing of the suspended part will bring a series of problems to the production process. For example, the spraying process cannot be uniformly applied to the surface of the equipment, the laser cutting energy is not uniform, so cutting is not possible or the thickness of the cut rod is not consistent, or the cutting position is shifted, the dimensions are not uniform, and the processing precision is not high, etc. As a result, the final stent product may cause a series of problems such as blood clots when used in the body. Based on this, it is necessary to provide a method to ensure that the stent always remains straight during processing, so as to ensure that the coating on the stent surface is uniform, the cutting pattern is uniform, and the detection result is highly accurate. Summary of the Invention
[0004] In response to the above technical problems, the technical solution of the present invention provides a method for keeping a long tubular implantable medical device straight, which can ensure that the long tubular implantable medical device, especially the openwork long tubular implantable medical device, is always kept in a relatively straight state during the processing or inspection process, and the angle between the connecting line between the highest or lowest point passed during its oscillation and the fixed point of the device fixed end and the straight line on which the center line of the fixing device is located is θ≦5°, or even θ≦3°, and at the same time, the pass rate of the appearance and dimensions of the workpiece in the processing process and the detection accuracy in the inspection process can reach 90% or even 95% or more.
[0005] The technical solution of the present invention provides a method for keeping a long tubular implantable medical device straight, in which the long tubular implantable medical device includes a fixed end and a suspended end, in which an external force is applied to the suspended end to ensure that the device is kept straight.
[0006] The long tubular implantable medical device in the present invention has small specifications, and the longer the tubular device, the longer the suspended part, and the more serious the vibration phenomenon. In a certain processing process, the processed device needs to rotate constantly, so the device will have a large vibration due to gravity and its own inertia, etc., and the vibration angle can reach 120°, that is, the highest point and the lowest point that the device passes through in the swing process are 2θ, and the angle between the connecting line and the fixed point of the fixed end of the device is 2θ, and the value of 2θ can reach 10°-120° in the swing process. Especially when the long tubular implantable medical device has a hollow structure, the vibration is more serious, and the swing angle 2θ can even reach 180°. Therefore, it is necessary to apply sufficient force to the surface of the device to achieve the effect of "pulling the tail of the device straight".
[0007] The above "highest point" and "lowest point" refer to the center points of the cross sections of the machine ends at which the machine reaches its highest or lowest position during the swing process.
[0008] In the above technical solution provided by the present invention, the external force provided is a magnetic field traction force; the magnitude of the magnetic field traction force acting on the implantable medical device is JPEG2024545309000002.jpg16170 where μ0 is the permeability of the magnetic medium in a vacuum state (i.e., the vacuum permeability, where μ0=4π×10 -7 N.A. -2 ), where x is the distance from the magnetic source to the outermost surface of the magnetic material at the suspended end of the device, dx is the integral of the distance from the magnetic source to the surface of the magnetic material, h is the length of the magnetic material in the device perpendicular to the surface, and F 牽 is the total traction force in the device subjected to the magnetic field, B is the magnetic induction strength on the surface of the permeable material on which the magnetic field acts, and S is the area of the surface on which the magnetic field acts on the permeable material.
[0009] The long tubular implantable medical device of the present invention can generate a corresponding force when induced by a magnetic field, but the manner in which the surface of the device receives the magnetic field traction force is not specifically limited. In some cases, the long tubular implantable medical device itself is magnetically conductive, for example, the entire suspended portion of the device in some embodiments, and even the entire device, can be magnetically conductive, and both can be subjected to the action of a magnetic field; in other embodiments, some portion of the device is magnetically conductive, for example, the coating of the device or the main material of the device is magnetically conductive, or a magnetically conductive material (such as a development structure) is present on a cross section of the device, ensuring that the device is subjected to the action of a magnetic field and thereby maintains the device in a straight state. In other cases, the device itself is not magnetically conductive, but an external magnetically conductive material, such as a magnetically conductive patch or the like, is attached to the outer surface of the device, allowing the device to be subjected to the action of a magnetic field and thereby maintain its straightness.
[0010] If the device is made of pure iron or iron alloy, and the device itself has magnetic conductivity, and either the suspended part or the entire device can conduct magnetic fields, the magnetic field acting on the device of the present invention at this point is JPEG2024545309000003.jpg12170, where μ0 is the permeability of the magnetic medium in a vacuum state, i.e., the vacuum permeability, μ0=4π×10 -7 N.A. -2 where x is the distance from the magnetic source to the outermost working surface at the suspended end of the equipment, dx is the integral of the distance from the magnetic source to the working surface of the equipment, h is the length of the suspended part of the equipment, and F 牽 is the total magnetic attraction force of the magnetic field acting on the equipment, B is the magnetic induction strength at the surface of the equipment where the magnetic field acts, and S is the area of the magnetic field and the surface of the equipment where the equipment acts.
[0011] In the present invention, the "area S of the magnetic field and the equipment acting surface" means the area of the covering material in any circumferential cross section where the equipment is subjected to the action of a magnetic force. When the equipment in the present invention has a hollow tubular structure, the "area S of the magnetic field and the equipment acting surface" is the area of the equipment support rod in the cross section, i.e., S 支持ロッド断面 The formula is the circumferential cross-sectional area S of the equipment outer diameter. 周方向 The coverage rate S of the material that covers the cross section of the equipment 断面被覆率 Multiply by, i.e.: S 機器ロッド断面 =S 周方向 ×S 断面被覆率 Formula II Here, the coverage rate S of the material that the device covers on the cross section 断面被覆率 is the area S of the support rod in the circumferential cross section 支持ロッド断面 and the circumferential cross-sectional area S of the stent outer diameter 周方向 is the ratio of JPEG2024545309000004.jpg11170
[0012] In addition, the above S 断面被覆率 , S 周方向 , S 支持ロッド断面 All of these are average values, and all of these are areas when the device is processed / in the processing process, not the areas when the device is implanted in the body and used inside the body.
[0013] In the present invention, when the device itself has only a portion of magnetic conductivity (internal magnetic conductivity) or has a magnetically permeable material (external magnetic conductivity) attached to its outer surface, especially when the magnetically permeable material at the internal or external magnetic conductive portion of the device has a very short length in the longitudinal direction of the device and can be ignored, the above traction force formula may be as follows: B 2 S JPEG2024545309000005.jpg15170In other words, the magnitude of the magnetic field traction force experienced by the equipment is related only to the area of the magnetic conductive material in the circumferential cross-sectional direction.
[0014] Since the magnetic field gradually weakens with increasing distance, for a constant magnetic field emitted by a magnetic source, the further away from the magnetic source, the smaller the magnetic induction strength of the magnetic field, so when the distance between the magnetic field and the outermost working surface of the suspended end of the implantable medical device is large, the magnetic induction strength emitted by the magnetic source needs to be increased accordingly in order to keep the final force acting on the device surface constant. When the magnetic source is far away from the outermost working surface of the suspended end of the implantable medical device, the required magnetic induction strength can reach 1000mT, and when the magnetic source is close to the outermost working surface of the suspended end of the implantable medical device, the magnetic induction strength generated by the magnetic source can meet the requirement even if it is 100mT. That is, in the above technical solution provided by the present invention, the magnetic induction strength B of the magnetic field generated by the magnetic source is B≦1000mT, including, but not limited to, any value below 1000, such as 200mT, 300mT, 400mT, 500mT, 600mT, 700mT, 800mT, 900mT, and further, the magnetic induction strength B of the magnetic field generated by the magnetic source is B≦750mT or B≦600mT, etc.
[0015] In the above technical solution provided by the present invention, the magnetic source generating the magnetic field traction force may be any apparatus and / or device capable of generating a magnetic field, such as a general permanent magnet, which can generate magnetism naturally, or a device or device capable of generating a magnetic field under the action of an external force, such as a magnetic field generated when electricity is applied. Furthermore, the magnetic source of the present invention includes, but is not limited to, a permanent magnet and an electromagnet, and may be a magnet, a magnetic iron, a coil generating a magnetic field, etc. It may be any one or more of a constant magnetic field, an alternating magnetic field, a pulsating magnetic field, and a pulsed magnetic field. In addition, the number of magnetic field sources is not limited to one, and may be one or a combination of multiple magnetic fields.
[0016] In the above technical solution provided by the present invention, the possible range of values of the distance x from the magnetic source to the outermost working surface of the suspended end of the implantable medical device is 0.1mm-100mm (including 0.5mm, 1mm, 3mm, 5mm, 7mm, 9mm, 15mm, 20mm, 25mm, 30mm, 35mm, 40mm, 45mm, 50mm, 55mm, 60mm, 65mm, 70mm, 75mm, 80mm, 85mm, 90mm, 95mm, 98mm, etc. and are not limited to these; furthermore, the distance x from the magnetic source to the outermost working surface of the suspended end of the implantable medical device may be in the interval of any two values between 0.1-100 mm, such as 0.1 mm-10 mm, 0.1 mm-15 mm, 0.1 mm-25 mm, 0.1 mm-50 mm, 0.1 mm-60 mm, 0.1 mm-70 mm, 0.1 mm-80 mm, 0.15 mm-80 mm, 0.15 mm-90 mm, etc.
[0017] In the present invention, the outermost working surface of the suspended end of the implantable medical device is the circumferential cross section perpendicular to the radial plane of the device at the point on the magnetic conductive material closest to the magnetic source, and when the entire device or the suspended portion of the device in the present invention is made of a magnetic permeable material, the outermost working surface of the suspended end of the implantable medical device refers to the circumferential cross section perpendicular to one radial plane where the suspended end of the device comes into contact with the air.
[0018] The present invention is a technical solution provided for the processing of implantable medical devices, which are particularly long and tubular. The longer the implantable medical device is, the lower the surface coverage rate will be, and the implantable medical device will be easily bent due to gravity and easily vibrated during rotation or vibration. Therefore, the length of the medical device required / applied in the human body is limited. Therefore, the present invention provides a long tubular device with a suspended part length of 5mm-200mm (the suspended part length is 10mm, 15mm, 20mm, 25mm, 30mm, 35mm, 40mm, 45mm, 50mm, 55mm, 60mm, 65mm, 70mm, 75mm, 80mm, 85mm, 90mm, 95mm, 100mm, 10 ... The present invention is applicable to long tubular instruments having a length of 5mm-200mm (including, but not limited to, 38mm, 80mm, 85mm, 90mm, 95mm, 100mm, 110mm, 120mm, 130mm, 140mm, 150mm, 160mm, 170mm, 180mm, 190mm, 200mm, etc.) that is in a straight line, and further applicable to long tubular instruments having a length of the suspended portion that is within the new interval range consisting of any two values within the 5mm-200mm interval, such as 38mm-150mm, 38mm-140mm, 15mm-150mm, 15mm-140mm, 20mm-150mm, 20mm-140mm.
[0019] In the above technical solution provided by the present invention, in order to ensure that the device basically maintains a straight state, that is, the angle θ between the most inclined position of the device and the center line of the fixing device is as small as possible, the value of the angle θ can be controlled to 5° and 5° or less, even 3° and 3° or less, so as to ensure that the pass rate of the appearance and dimensions of the workpiece in the processing process and the detection accuracy in the detection process reach 90% or more, so that a sufficient external force or magnetic traction force needs to be applied to the suspended end of the stent. However, the magnetic field traction force applied to the implantable medical device should not be too large. If it is too large, the device will easily break away from the fixed end and lose stability, that is, the magnitude of the magnetic field traction force acting on the implantable medical device should be smaller than the pulling force of the fixed end on the device, so that the fixed end does not move left and right or up and down; and when the long tubular implantable medical device in the present invention has an openwork structure, if the external force applied is too large, the device is easily pulled and deformed. Therefore, in the present invention, it is necessary to limit the magnitude of the magnetic field attraction force applied to the implantable medical device so that the magnitude of the magnetic field attraction force acting on the device is moderate. In the technical solution provided by the present invention, the magnitude of the magnetic field attraction force acting on the device is 1-40 times the gravity force acting on the implantable medical device, including but not limited to 2 times, 3 times, 5 times, 7 times, 10 times, 12 times, 15 times, 18 times, 20 times, 23 times, 25 times, 28 times, 30 times, 35 times, 38 times, 40 times, etc. Furthermore, the magnitude of the magnetic field attraction force acting on the implantable medical device is 1-28 times, 1-20 times, 5-35 times, 3-35 times, 3-40 times, etc., of the gravity force acting on the implantable medical device.
[0020] In the spraying process of a long tubular implantable medical device, the spray liquid is viscous, and when the spray liquid is sprayed onto the end of the stent with the jig during spraying, the device and the jig are easily adhered to each other, and the coating on the surface of the device is torn in the process of separating it from the jig, so it is currently common to spray the device in two or more steps, and in this case, the length of the jig at the clamping end of the implantable medical device must not exceed the length of the device, that is, the length of the device must be longer than the length of the jig. In the above technical solution provided by the present invention, the length of the jig may be 2 / 3 or less, 1 / 2 or less, 1 / 3 or less, 1 / 4 or less, or 1 / 5 or less of the length of the implantable medical device, and the length of the jig located inside the device may be 0 mm.
[0021] In the above technical solution provided by the present invention, the fixing manner of the fixed end of the implantable medical device is diverse, and may be clamped by a jig, fixed by physical interference fit, or fixed by magnetic force or chemical means, that is, the fixing manner of the fixed end of the device in the technical solution provided by the present invention includes, but is not limited to, several fixing manners such as clamping, physical interference fit, magnetic force fixation, and chemical fixation.
[0022] The above manufacturing method provided by the present invention is applicable to the processing of long tubular implantable medical devices of all outer diameters, wall thicknesses and coverage rates, especially applicable to the processing of openwork long tubular implantable medical devices, and ensures that the long tubular implantable medical devices remain straight during the processing process.
[0023] In the above technical solution provided by the present invention, the outer diameter of the long tubular implantable medical device is 1.0mm-20.0mm; further, the outer diameter of the long tubular implantable medical device is 1.0mm-15.0mm; further, the outer diameter of the long tubular implantable medical device is 1.0mm-10.0mm.
[0024] In the above technical solution provided by the present invention, the wall thickness of the long tubular implantable medical device is 10 μm-600 μm (20 μm, 30 μm, 40 μm, 50 μm, 80 μm, 100 μm, 120 μm, 150 μm, 175 μm, 200 μm, 225 μm, 250 μm, 280 μm, 300 μm, 320 μm, 350 μm, 380 μm). , 425 μm, 450 μm, 475 μm, 500 μm, 520 μm, 550 μm, 560 μm, 580 μm, 600 μm, etc.); further, the wall thickness of the long tubular implantable medical device is 10 μm-500 μm; further, the wall thickness of the long tubular implantable medical device is 15 μm-450 μm.
[0025] In the above technical solutions provided by the present invention, the coverage rate of the cross section of the long tubular implantable medical device is 0.1%-35% (including but not limited to 1%, 5%, 8%, 10%, 12%, 14%, 16%, 18%, 20%, 22.5%, 25%, 28%, 30%, 33%, 34.5%, etc.); further, the coverage rate of the cross section of the long tubular implantable medical device is 0.1%-30%; further, the coverage rate of the cross section of the long tubular implantable medical device is 0.1%-25%.
[0026] In the above technical solution provided by the present invention, the long tubular implantable medical device is an openwork design, and the coverage of the device surface is 5%-60% (including but not limited to 6%, 8%, 10%, 12%, 14%, 16%, 18%, 20%, 22.5%, 25%, 28%, 30%, 33%, 36%, 40%, 45%, 50%, 55%, 58%, etc.); and The coverage of the tubular implantable medical device is 5%-55%; further, the coverage of the tubular implantable medical device is within the interval consisting of any two values within the range of 5%-60%, such as 5%-50%, 8%-55%, 8%-50%, 10%-55%, 10%-50%, 8%-45%, 8%-40%, 5%-45%, 5%-40%, 10%-45%, 10%-40%, 8%-35% or 10%-35%.
[0027] In the present invention, the "surface coverage of the device" refers to the surface coverage of the device material under the device diameter condition during processing, that is, the ratio of the surface area covered by the device material to the total cylindrical side area of the stent covering part, and the formula is as follows: JPEG2024545309000006.jpg8170 where: Sr: The area actually filled / occupied on the outer surface of the device pattern during processing, the outer surface area of the stent is measured by CAD software; Ss: total cylindrical side surface area of the stent during processing, Ss = π × D1 × L1 (2) D1: diameter of stent during processing;
[0028] The terms "outer diameter", "wall thickness", "cross-sectional coverage" and "surface coverage" of the long tubular implantable medical device according to the present invention all refer to the corresponding values when the long tubular implantable medical device is in a processed state. In other words, they refer to the values of the "outer diameter", "wall thickness", "cross-sectional coverage" and "surface coverage" of the tubular material of the long tubular implantable medical device being processed or being processed.
[0029] In the technical solution provided by the present invention, in some other embodiments, the long tubular implantable medical device is a luminal prosthesis, further, the long tubular implantable medical device is a blood flow guide device, and further, the long tubular implantable medical device is a vascular support. In some embodiments of the present invention, the long tubular implantable medical device is a stent; in some other embodiments, the long tubular implantable medical device is a tubular material that is processed into a stent, and in some embodiments, the long tubular implantable medical device is a semi-finished product that is processed into a final finished stent; in some other embodiments, the long tubular implantable medical device can be any internally implantable long and lightweight medical device; and in some further embodiments, the long tubular implantable medical device is a raw material that is processed into a stent, a semi-finished product, or a finished stent.
[0030] In the above technical solution provided by the present invention, the implantable medical device itself has magnetic conductivity; or a magnetic patch is added to the implantable medical device, and the magnetic patch can be attached to any position on the device, but it is more effective if it is attached to a part that is not clamped by a jig and is close to the magnetic source, including but not limited to adding magnetic conductive development points to both ends of the stent, or applying a magnetic conductive coating to the surface of the stent. Furthermore, the magnetic patch is preferably as close to the magnetic source as possible. The number of magnetic patches attached in the present invention may be one or more, and the shape of the magnetic patch is not limited, but it can generate sufficient magnetic force to keep the stent in a straight state in combination with the magnetic field strength generated by the magnetic source and the distance from the device working surface to the magnetic source.
[0031] The method is applicable to multiple steps in the manufacturing process of openwork design long-tube instruments, including but not limited to spraying, cutting, detecting, coating, etc.
[0032] In the above technical solutions provided by the present invention, in some embodiments, the material of the device may be pure iron-based, iron-based alloy, or any other pure metal or alloy material with magnetic conductivity; in other embodiments, the material of the device may be a material that does not have magnetic conductivity by itself, such as polylactic acid.
[0033] In the present invention, "fixing" may mean fixing the fixed end of the equipment at a predetermined position by the force due to the interaction between the jig and the equipment; or it may mean fixing the fixed end of the equipment at a specific position by an external force such as a magnetic force; it may be fixing by an interference fit, or fixing by the chemical action of a magnetic field, etc.
[0034] In the present invention, for the sake of convenience, the term "long tubular implantable medical device" is abbreviated, i.e., "device," "medical device," and "implantable medical device" described in the present invention all refer to "long tubular implantable medical device."
[0035] A "long tubular" implantable medical device, as used herein, refers to a device whose length is greater than its outer diameter, particularly a device having a suspended length of 5 mm or more, and more particularly a device having a suspended length of 10 mm or more.
[0036] In the present invention, "runout" means that the central axes of the stent front end and rear end do not overlap during processing.
[0037] "Straight" as used herein means that the angle θ between the most inclined position of the implantable medical device and the center line of the fixation device is ≦5°.
[0038] In the present invention, the symbol " / " means "or", for example, "required / applied in the body" means required or applied in the body.
[0039] It should be understood that the terminology used herein is for the purpose of describing particular exemplary embodiments only and is not intended to be limiting. As used herein, the singular forms "a," "an," and "said" can also refer to the plural, unless the context clearly indicates otherwise. The terms "comprise," "include," "contain," and "have" are inclusive and thus indicate the presence of a described feature, step, operation, element, and / or component, but do not exclude the presence or addition of one or more other features, steps, operations, elements, components, and / or combinations thereof. The methods, steps, processes, and operations described herein should not be construed as requiring performance in the particular order described or illustrated, unless the order of performance is explicitly indicated. It should also be understood that other or alternative steps may be used. [Brief description of the drawings]
[0040] Various other advantages and benefits will become apparent to those skilled in the art upon reading the following detailed description of the preferred embodiments. The drawings are only for purposes of illustrating the preferred embodiments and are not intended to limit the invention. In the drawings, like parts are designated by like reference numerals throughout. Where: [Figure 1] FIG. 1 is a schematic diagram of the state of the stent spray in Example 1; [Diagram 2] FIG. 2 is a schematic diagram of the coupling method between the development hole and the stent in Example 5; [Diagram 3] FIG. 3 is a schematic diagram showing the state of the stent cutting process in Example 6. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0041] Hereinafter, the embodiments of the present invention will be described in detail with reference to the drawings. Although the drawings show exemplary embodiments of the present invention, it should be understood that the present invention can be embodied in various forms without being limited to the embodiments described herein. On the contrary, these embodiments are provided to enable a more complete understanding of the present invention and to fully convey the scope of the present invention to those skilled in the art.
[0042] Test Method: 1. Coating thickness test The stent is placed under the ultrasonic atomizing nozzle, sprayed, and coated with a coating layer on the surface of the stent. Then, the thickness of the coating layer on the surface of the stent is measured using Sensofar - a non-contact 3D optical profilometer, based on the principle of white light interference technology. The coating thickness is measured at multiple points on the entire stent, and the maximum and minimum coating thicknesses are compared. The difference between the two should not exceed 2 μm. 2. Stent rod width test The cut stents are placed under a three-dimensional microscope for observation, and all stent levers are visually observed to find and measure the maximum and minimum rod width levers. Rods with a difference between the measured maximum and minimum rod widths exceeding 16 μm are defined as male and female rods, and the number of stents cutting male and female rods is counted. That is, the cut dimension pass rate = number of male and female rod stents / number of cut stents 3. Measurement of the inclination angle Determine the length h of the suspended part of the stent, measure the height b of the center point of the cross section of the most distal end of the stent and the horizontal center line of the clamped part, and use trigonometric functions to obtain The result is JPEG2024545309000007.jpg8170, and the magnitude of the inclination angle θ is obtained. 4. Cutting visual inspection The cut stents are placed under a three-dimensional microscope and observed to see whether there are any incompletely blanked areas on the surface of the stent, and the number of incompletely blanked stents is counted. That is, the pass rate of cut appearance = number of stents not completely blanked / number of cut stents.
[0043] Example 1 One end of an iron-based absorbable drug-eluting peripheral stent with a length of 118 mm (stent processed outer diameter is 1.58 mm, stent surface coverage is 30%, stent wall thickness is 70 μm, support rod coverage of the circumferential cross section of the stent is 5%, and stent mass m is 112.53 mg) is fixed by physical interference fit using a 59 mm long jig, and the clamped length h is 59 mm. A magnet capable of emitting a maximum magnetic induction strength Bmax of 400 mT is used as a magnetic source to apply magnetic traction to the stent, and the magnet is placed 1 mm away from the outermost working surface of the suspended end of the stent, resulting in a relatively straight state. JPEG2024545309000008.jpg32170The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. The stent coating thickness after spraying is measured using Sensofar - a non-contact 3D optical profilometer, and the difference between the maximum coating thickness and the minimum coating thickness is 0.5 μm.
[0044] Example 2 One end of an iron-based absorbable drug-eluting peripheral stent with a length of 200 mm (the stent processed outer diameter is 1.58 mm, the stent surface coverage is 30%, the stent wall thickness is 60 μm, the support rod coverage of the stent circumferential cross section is 4%, and the stent mass m is 152.16 mg) is fixed by physical interference fit using a 100 mm long jig, the clamped length h is 100 mm, and a magnet capable of emitting a maximum magnetic induction strength Bmax of 600 mT is used as a magnetic source to apply magnetic traction force to the stent, and the magnet is placed 1 mm away from the outermost working surface of the suspended end of the stent, resulting in the stent being in a relatively straight state. JPEG2024545309000009.jpg32170The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. Sensofar - a non-contact 3D optical profilometer is used to measure the stent coating thickness after spraying, and the difference between the maximum and minimum coating thickness is 1 μm.
[0045] Example 3 One end of an iron-based absorbable drug-eluting peripheral stent with a length of 38 mm (the stent processed outer diameter is 1.2 mm, the stent surface coverage is 40%, the stent wall thickness is 80 μm, the support rod coverage of the stent circumferential cross section is 10%, and the stent mass m is 22.83 mg) is fixed by physical interference fit using a 15 mm long jig, the clamped length h is 23 mm, and a magnetic traction force is applied to the stent using a magnet that can emit a maximum magnetic induction strength Bmax of 300 mT as a magnetic source, and the magnet is placed 3 mm away from the outermost working surface of the suspended end of the stent, resulting in a relatively straight state. JPEG2024545309000010.jpg27170The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. The stent coating thickness after spraying is measured using Sensofar - a non-contact 3D optical profilometer, and the difference between the maximum coating thickness and the minimum coating thickness is 1 μm.
[0046] Example 4 One end of a cobalt alloy stent with a length of 118 mm (the outer diameter of the stent when processed is 2.4 mm, the stent surface coverage is 20%, the stent wall thickness is 100 μm, the support rod coverage of the circumferential cross section of the stent is 4%, and the stent mass m is 98.8 mg) is fixed by physical interference fit using a 50 mm long jig, the length h without the clamping portion is 68 mm, and a magnetic traction force is applied to the stent using a magnet as a magnetic source that can emit a maximum magnetic induction strength Bmax of 300 mT, and the magnet is placed 1 mm away from the outermost working surface of the suspended end of the stent, resulting in the stent being in a relatively straight state. JPEG2024545309000011.jpg32170The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. Sensofar - a non-contact 3D optical profilometer is used to measure the stent coating thickness after spraying, and the difference between the maximum and minimum coating thickness is 0.5 μm.
[0047] Example 5 One end of an iron-based absorbable drug-eluting stent with a length of 58 mm (stent processed outer diameter is 8.0 mm, stent surface coverage is 11%, stent wall thickness is 150 μm, support rod coverage of the circumferential cross section of the stent is 0.8%, and stent mass m is 215.98 mg) is fixed by physical interference fit in a 15 mm long jig, and the clamped length h is 43 mm. A magnet capable of emitting a maximum magnetic induction strength Bmax of 600 mT is used as a magnetic source to apply magnetic traction to the stent, and the magnet is placed 3 mm away from the outermost working surface of the suspended end of the stent, resulting in a relatively straight state. JPEG2024545309000012.jpg27170The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. Sensofar - a non-contact 3D optical profilometer is used to measure the stent coating thickness after spraying, and the difference between the maximum and minimum coating thickness is 1μm.
[0048] Example 6 A magnesium alloy stent with a length of 68 mm (stent mass m is 57.26 mg) is fitted with a 0.5 mm cross-sectional area stent at each end. 2 The development holes are cut out, and the development holes are filled with nickel material (shown in Figure 2) with excellent magnetic conductivity. The length of the jig used is 30 mm, the length h of the stent without the clamping part is 38 mm, and a magnet capable of emitting a maximum magnetic induction strength Bmax of 300 mT is used as a magnetic source to apply a magnetic traction force to the stent. When the magnet is placed 3 mm away from the development hole, the stent is in a relatively straight state. At this time, the stent receives a traction force only at the development point, and the length h of the development point in the stent radial direction is too small, so the traction force received by the stent is expressed by the formula: JPEG2024545309000013.jpg9170, and based on the Gaussmeter, the magnetic induction strength B=150mT was measured when the magnet was at x=3, and F 牽 = 0.00447N, and the gravity F acting on the suspended part of the stent is 重 =0.00032N. At this time, F 牽 =14F 重 At this time, the height b of the center point of the cross section at the farthest end of the stent and the horizontal center line of the clamping part is 2.65 mm, and θ is calculated as 4°<5° based on trigonometric functions. The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. The stent coating thickness after spraying is measured using Sensofar - a non-contact 3D optical profilometer, and the difference between the maximum coating thickness and the minimum coating thickness is 0.5 μm.
[0049] Example 7 One end of an iron-based absorbable drug-eluting peripheral stent (with a stent processed outer diameter of 1.58 mm, a stent surface coverage of 30%, a stent wall thickness of 70 μm, a support rod coverage of the stent circumferential cross section of 5%, and a stent mass m of 36.24 mg) is attracted and fixed with a magnet, and a clamped length h of 38 mm and a magnet capable of emitting a maximum magnetic induction strength Bmax of 400 mT is used as a magnetic source to apply a magnetic traction force to the stent, and the magnet is placed 1 mm away from the outermost working surface of the suspended end of the stent, resulting in the stent being in a relatively straight state. JPEG2024545309000014.jpg27170The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. Sensofar - a non-contact 3D optical profilometer is used to measure the stent coating thickness after spraying, and the difference between the maximum and minimum coating thickness is 0.5 μm.
[0050] Example 8 Referring to FIG. 3, a metal iron pipe with an outer diameter of 1.6 mm and a length of 200 mm to be cut is clamped by a fixing device, the left side rotates the feed material at a constant speed of 6 mm / s, and the right side cuts the metal into a stent with a certain pattern with a laser. When a long stent is cut as in state 1, if only a part of the stent completes the pattern cutting, the stent will maintain a certain straightness due to the hardness of the metal pipe material itself, and will not affect the energy that the laser reaches the material surface. When the stent is cut in state 2, the length of the stent cut reaches a certain value, and if the length of the suspended openwork stent is longer, the stent at the suspended end will be tilted to a certain extent due to gravity, and the tilt angle θ will increase as the stent at the part where the pattern cutting is completed becomes longer, and a deviation will occur between the distance from the laser light source to the cutting part on the stent surface and the distance of the original laser cutting setting. The larger the deviation, the weaker the laser energy reaching the material surface, resulting in the phenomenon of failure to cut or large dimensional deviation of the stent pattern after cutting. In this case, a variable electromagnetic source of a magnetic field capable of emitting a magnetic induction strength of up to 1000 mT to the suspended end of the stent can be added, and the magnitude of the magnetic induction strength emitted by the magnetic source can be adjusted, and / or the magnitude of the magnetic induction strength received by the suspended end of the metal tube can be adjusted by adjusting the distance between the magnetic source and the metal tube. In this embodiment, at the beginning of cutting, the magnetic source is placed 5 mm from the end of the stent. As the metal tube moves toward the magnetic source, the openwork stent gradually becomes longer, while the distance of the stent from the magnetic source becomes shorter. At this time, the magnetic source does not need to be adjusted. As more and more of the subsequent metal rod is cut, the length of the suspended end becomes longer. The magnetic field adjusts the magnetic field magnitude according to the distance / angle that the stent moves away from the original center position to ensure that the angle that the stent moves away from the central axis is always kept within 5°. After cutting is completed, the height b of the center point of the cross section of the farthest end of the stent and the horizontal center line of the clamping part is calculated to be 13.95 mm, and θ=4°<5°. At the same time, the cut stent is put into a three-dimensional microscope for inspection, and the cut appearance pass rate is 97% and the cut dimension pass rate is 95%.
[0051] Comparative Example 1 One end of an iron-based absorbable drug-eluting peripheral stent with a length of 118 mm (stent processed outer diameter is 1.58 mm, stent surface coverage is 30%, stent wall thickness is 70 μm, stent circumferential cross-section support rod coverage is 5%, and stent mass m is 112.53 mg) is fixed with a 59 mm long jig, and the length h without the clamping part is 59 mm. At this time, the height b of the cross-section center point of the farthest end of the stent and the horizontal center line of the clamping part is 37.92 mm, and θ = 40 ° is calculated based on trigonometric functions. The stent in the above state is placed under the ultrasonic atomizing nozzle and sprayed. The stent coating thickness after spraying is measured using Sensofar-non-contact 3D optical profilometer, and the difference between the maximum coating thickness and the minimum coating thickness is 7 μm.
[0052] The above are preferred specific embodiments of the present invention, but the scope of protection of the present invention is not limited thereto, and any modifications or replacements that can be easily thought of by those skilled in the art within the technical scope disclosed in the present invention are all included in the scope of protection of the present invention. In this application document, only stents are described as examples, and the method provided in the present invention does not represent the application only to the processing process of stents, and any other method of holding a long tubular implantable device straight by magnetic force is also included in the scope of protection of the present invention. Therefore, the scope of protection of the present invention should be based on the scope of protection of the claims.
Claims
1. A method for holding a long tubular implantable medical device in a straight position, the long tubular implantable medical device having a fixed end and a suspended end, and an external force being applied to the suspended end of the long tubular implantable medical device to ensure that the device is held in a straight position.
2. The external force is a magnetic field attraction force; the magnitude of the magnetic field attraction force acting on the implantable medical device is where: μ 0 is the vacuum permeability of the magnetic medium, x is the distance from the magnetic source to the outermost surface of the magnetic material at the suspended end of the device, dx is the integral of the distance from the magnetic source to the surface of the magnetic material, h is the length of the magnetic material on the device in the direction perpendicular to the surface, F 牽 2. The method of claim 1, wherein: m is the total magnetic attraction force of the magnetic field on the device; B is the magnetic induction strength of the magnetic field on the surface of the magnetic permeable material; and S is the area of the surface of the magnetic field and the magnetic permeable material.
3. 2. The method for holding a long tubular implantable medical device straight as described in claim 1, wherein the magnetic source generating the magnetic field traction force is a permanent magnet or an electromagnet.
4. 2. The method for keeping a long tubular implantable medical device straight as described in claim 1, wherein the distance x from the magnetic source to the outermost active surface of the suspended end magnetic permeable material of the long tubular implantable medical device can range from 0.1 to 100 mm.
5. 2. The method for holding a long tubular implantable medical device straight as described in claim 1, wherein the magnetic induction strength B of the magnetic field generated by the magnetic source is ≦1000 mT.
6. The method for keeping a long tubular implantable medical device straight as claimed in claim 1, wherein the length of the hollowed-out portion of the implantable medical device is 5mm-200mm.
7. The method for keeping a long tubular implantable medical device straight, as described in claim 1, characterized in that the magnitude of the magnetic field traction force acting on the implantable medical device is 1-40 times the gravity experienced by the suspended portion of the implantable medical device.
8. The length of the device fixed to the fixed end of the implantable medical device is L 固定 ≦2 / 3×L 機器 2. The method of claim 1 for holding a long tubular implantable medical device straight,
9. The method for holding a long tubular implantable medical device straight as described in claim 1, characterized in that the fixing manner of the fixed end of the implantable medical device includes clamping, physical interference fitting, magnetic linking, and chemical fixing.
10. 2. The method for keeping a long tubular implantable medical device straight as claimed in claim 1, wherein the outer diameter of the long tubular implantable medical device is 1.0mm-20.0mm.
11. 2. The method for keeping a long tubular implantable medical device straight as claimed in claim 1, wherein the wall thickness of the long tubular implantable medical device is 10 μm-600 μm.
12. 2. The method for keeping a long tubular implantable medical device straight as claimed in claim 1, wherein the coverage of the cross section of the long tubular implantable medical device is 0.1%-35%.
13. The method for keeping a long tubular implantable medical device straight as claimed in claim 1, characterized in that the coverage of the surface of the long tubular implantable medical device is 5%-60%.
14. 2. The method for keeping a long tubular implantable medical device straight as described in claim 1, characterized in that the implantable medical device itself is magnetically conductive; or a magnetically conductive patch is added to the implantable medical device.
15. 2. The method for keeping a long tubular implantable medical device straight as claimed in claim 1, wherein the long tubular implantable medical device is a raw material to be processed into a stent, a semi-finished product, or a finished stent.
Citation Information
Patent Citations
Manufacturing method of stent
JP2005198853A
Cited By
Tantalum metal porous conical pile loaded with bisphosphonate and preparation method of tantalum metal porous conical pile
CN119326559A
